Through the looking glass

Joshi J. Alumkal

    Research output: Contribution to journalComment/debatepeer-review


    DNA methylation is a common mode of gene silencing in cancer, and MDS remains the poster child for a disease in which targeting the DNMT enzymes leads to clinical benefit. 1-4 However, some important questions remain unanswered, 2 of which are directly addressed in this issue of Blood by Figueroa and colleagues 5: What pivotal gene sets are silenced by DNA methylation in MDS and de novo AML, a question that begs a reference to the patterns of normal marrow cells on a genome-wide scale, and what global changes in DNA methylation can be achieved when treating patients with DNMT inhibitors?

    Original languageEnglish (US)
    Pages (from-to)3363-3364
    Number of pages2
    Issue number16
    StatePublished - Nov 19 2009

    ASJC Scopus subject areas

    • Biochemistry
    • Immunology
    • Hematology
    • Cell Biology


    Dive into the research topics of 'Through the looking glass'. Together they form a unique fingerprint.

    Cite this